FGF4 protects the liver from nonalcoholic fatty liver disease by activating the AMP-activated protein kinase-Caspase 6 signal axis

Song, LT; Wang, LY; Hou, YS; Zhou, J; Chen, CC; Ye, XX; Dong, WLY; Gao, H; Liu, Y; Qiao, GT; Pan, TT; Chen, Q; Cao, Y; Hu, FJ; Rao, ZH; Chen, YJ; Han, Y; Zheng, MH; Luo, YD; Li, XK; Chen, YP; Huang, ZF

Li, XK; Huang, ZF (通讯作者)，Wenzhou Med Univ, Sch Pharmaceut Sci, 01 North Ctr Rd, Wenzhou 325035, Zhejiang, Peoples R China.;Chen, YP (通讯作者)，Wenzhou Med Univ, Dept Infect Dis, Zhejiang Prov Key Lab Accurate Diag & Treatment C, Affiliated Hosp 1, 28 West Fanhai Rd, Wenzhou 325035, Zhejiang, Peoples R China.

HEPATOLOGY, 2022; 76 (4): 1105

Abstract

Background and Aims NAFLD represents an increasing health problem in association with obesity and diabetes with no effective pharmacotherapies. Growin......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索